Search
for
Sort by
Research 301–330 of 1000+
- Randomized trial of microneedling combined with 2% minoxidil topical solution for the treatment of female pattern hair loss in a Chinese population
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis
- Clinical Efficacy and Safety of Pulsed Dye Laser Combined with Pingyangmycin on Hyperplastic Scar after Acne
- Aceclofenac-induced erythema annulare centrifugum
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis
- Long-term (10-year) efficacy of finasteride in 523 Japanese men with androgenetic alopecia
- Microneedles: Selected Applications for Pediatrics
- Clinical pearls addressing hair growth and loss in transgender patients on hormone replacement therapy
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Madarosis: A marker of many Maladies
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Dermatologic Adverse Events from Cancer Treatments
- Synthetic hair reactions and treatment of complications: Case reports
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- Psoriasiform skin reaction due to Brazilian keratin treatment
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Finasteride-Induced Neuropsychiatric Reactions
- Cutaneous complications of chemotherapeutic agents
- Solitary fixed drug eruption caused by finasteride
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Adverse effects of common medications on male fertility
- Liposomes with an Ethanol Fraction as an Application for Drug Delivery